American International Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,004
| Closed | -$1.55M | – | 3043 |
|
|
2022
Q3 | $1.55M | Buy |
30,004
+424
| +1% | +$17.5K | 0.01% | 1012 |
|
|
2022
Q2 | $733K | Buy |
29,580
+2,774
| +10% | +$61.1K | 0.01% | 1372 |
|
|
2022
Q1 | $672K | Sell |
26,806
-1,888
| -7% | -$53.1K | ﹤0.01% | 1563 |
|
|
2021
Q4 | $1.04M | Sell |
28,694
-858
| -3% | -$30.1K | 0.01% | 1407 |
|
|
2021
Q3 | $505K | Sell |
29,552
-702
| -2% | -$10.9K | ﹤0.01% | 1852 |
|
|
2021
Q2 | $405 | Buy |
30,254
+1,353
| +5% | +$33.3K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $1.48K | Buy |
28,901
+76
| +0.3% | +$4.57K | 0.01% | 1273 |
|
|
2020
Q4 | $1.78K | Sell |
28,825
-827
| -3% | -$47.3K | 0.01% | 1127 |
|
|
2020
Q3 | $1.63M | Buy |
29,652
+2,451
| +9% | +$132K | 0.01% | 1032 |
|
|
2020
Q2 | $1.56M | Buy |
27,201
+3,082
| +13% | +$168K | 0.01% | 1044 |
|
|
2020
Q1 | $969K | Sell |
24,119
-1,393
| -5% | -$59.2K | 0.01% | 1125 |
|
|
2019
Q4 | $1.01M | Sell |
25,512
-215
| -0.8% | -$3.77K | ﹤0.01% | 1330 |
|
|
2019
Q3 | $174K | Sell |
25,727
-180
| -0.7% | -$1.35K | ﹤0.01% | 2265 |
|
|
2019
Q2 | $241K | Buy |
25,907
+11,580
| +81% | +$134K | ﹤0.01% | 2116 |
|
|
2019
Q1 | $199K | Sell |
14,327
-463
| -3% | -$5.29K | ﹤0.01% | 2217 |
|
|
2018
Q4 | $161K | Sell |
14,790
-114
| -0.8% | -$1.2K | ﹤0.01% | 2311 |
|
|
2018
Q3 | $188K | Buy |
14,904
+626
| +4% | +$7.54K | ﹤0.01% | 2461 |
|
|
2018
Q2 | $188K | Sell |
14,278
-1,517
| -10% | -$18.1K | ﹤0.01% | 2393 |
|
|
2018
Q1 | $215K | Sell |
15,795
-849
| -5% | -$8.76K | ﹤0.01% | 2216 |
|
|
2017
Q4 | $99K | Buy |
16,644
+280
| +2% | +$1.92K | ﹤0.01% | 2740 |
|
|
2017
Q3 | $121K | Buy |
16,364
+1,223
| +8% | +$10.2K | ﹤0.01% | 2556 |
|
|
2017
Q2 | $142K | Buy |
15,141
+1,939
| +15% | +$14.2K | ﹤0.01% | 2495 |
|
|
2017
Q1 | $96K | Buy |
13,202
+933
| +8% | +$6.72K | ﹤0.01% | 2614 |
|
|
2016
Q4 | $91K | Sell |
12,269
-32
| -0.3% | -$230 | ﹤0.01% | 2660 |
|
|
2016
Q3 | $74.3K | Buy |
12,301
+18
| +0.1% | +$85 | ﹤0.01% | 2776 |
|
|
2016
Q2 | $55.2K | Sell |
12,283
-4,100
| -25% | -$15.4K | ﹤0.01% | 2922 |
|
|
2016
Q1 | $41K | Hold |
16,383
| – | – | ﹤0.01% | 3982 |
|
|
2015
Q4 | $133K | Sell |
16,383
-29
| -0.2% | -$205 | ﹤0.01% | 3237 |
|
|
2015
Q3 | $99K | Buy |
16,412
+19
| +0.1% | +$137 | ﹤0.01% | 3492 |
|
|
2015
Q2 | $135K | Sell |
16,393
-806
| -5% | -$6.4K | ﹤0.01% | 3406 |
|
|
2015
Q1 | $130K | Hold |
17,199
| – | – | ﹤0.01% | 3360 |
|
|
2014
Q4 | $117K | Sell |
17,199
-682
| -4% | -$3.61K | ﹤0.01% | 3450 |
|
|
2014
Q3 | $80.5K | Sell |
17,881
-12
| -0.1% | -$63 | ﹤0.01% | 3718 |
|
|
2014
Q2 | $105K | Buy |
17,893
+1,177
| +7% | +$6.61K | ﹤0.01% | 3545 |
|
|
2014
Q1 | $111K | Buy |
16,716
+401
| +2% | +$2.79K | ﹤0.01% | 3346 |
|
|
2013
Q4 | $94.5K | Sell |
16,315
-163
| -1% | -$840 | ﹤0.01% | 3375 |
|
|
2013
Q3 | $91.6K | Buy |
16,478
+12,742
| +341% | +$138K | ﹤0.01% | 3386 |
|
|
2013
Q2 | $52.8K | Buy |
+3,736
| New | +$48.4K | ﹤0.01% | 3548 |
|
Other funds holding CCXI
American International Group's CCXI Position: Q4 2022 in Review
American International Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 30,004 shares — an estimated $1.55M sold.
American International Group first reported a position in CCXI in Q2 2013 and held it in 38 quarters. The position peaked at $1.63M in Q3 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- American International Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- American International Group sold 30,004 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.55M.
- American International Group first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 38 quarters.
- American International Group's ChemoCentryx, Inc. position peaked at $1.63M in Q3 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.